genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2017
Toll-like receptors
Drug Discovery
Two Different Genetic Conditions Can Combine to Cause Severe Infection
Industry News
Eisai Launches Discovery Innovation Unit in Massachusetts
Cancer
Humoral, Cellular Activity of MUC1 Vaccine Shrinks Tumors In Vivo
Cancer
Merck KGaA Returns All Rights to Anticancer TLR9 Agonists to Idera
News
AstraZeneca Pays Dynavax $3M to Speed Up Start of Asthma Drug Trials
News
Nobel Prize for Physiology or Medicine Shared Between Discoverers of Innate Immunity Activation and Dendritic Cells
Drug Discovery
MedImmune Nabs Rights to IDC’s GLA Adjuvant for Infectious Disease Vaccines
Insights
Lupus Drug Development Remains Risky Business
Insights
Systems Biology Transforms Vaccine Design
Cancer
Good and Bad News at Idera
1
2
3
Page 2 of 3
Scroll Up
Scroll Up
